KalVista Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q2 2024 | 1 | -$0.92 | -$0.92 | -$0.92 |
| Q3 2024 | 4 | -$0.95 | -$0.92 | -$0.93 |
| Q1 2025 | 4 | -$1.07 | -$0.68 | -$0.91 |
| Q2 2025 | 2 | -$0.84 | -$0.84 | -$0.84 |
| Q3 2025 | 2 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2025 | 2 | -$0.75 | -$0.75 | -$0.75 |
| Q1 2026 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q2 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
KalVista Pharmaceuticals, Inc. Earnings Date And Information
KalVista Pharmaceuticals, Inc. last posted its earnings results on Thursday, September 5th, 2024. The company reported $-0.87 earnings per share for the quarter, topping analysts' consensus estimates of $-0.95 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. KalVista Pharmaceuticals, Inc. has generated $-3 earnings per share over the last year ($-3.44 diluted earnings per share) and currently has a price-to-earnings ratio of -3.67. KalVista Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 4th, 2024 based on prior year's report dates.
KalVista Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/05/2024 | Q1 2025 | -$0.95 | -$0.87 | 0.08 | $0 | $0 |
| 07/11/2024 | Q4 2024 | -$0.71 | -$1.02 | -0.31 | $1.21 M | |
| 03/11/2024 | Q3 2024 | -$0.75 | -$0.84 | -0.09 | $0 | |
| 12/07/2023 | Q2 2024 | -$0.71 | -$0.80 | -0.09 | $0 | |
| 09/07/2023 | Q1 2024 | -$0.83 | -$0.74 | 0.09 | $0 | |
| 07/07/2023 | Q4 2023 | -$1.17 | $0 | |||
| 03/09/2023 | Q3 2023 | -$0.97 | -$0.51 | 0.46 | $0 | |
| 12/08/2022 | Q2 2023 | -$1.04 | -$0.75 | 0.29 | $0 | |
| 09/08/2022 | Q1 2023 | -$1.02 | -$0.94 | 0.08 | $0 | |
| 07/07/2022 | Q4 2022 | -$1.06 | -$0.90 | 0.16 | $0 | |
| 03/10/2022 | Q3 2022 | -$0.91 | -$0.92 | -0.01 | $0 | |
| 12/09/2021 | Q2 2022 | -$0.78 | -$0.80 | -0.02 | $0 | |
| 09/09/2021 | Q1 2022 | -$0.73 | -$0.66 | 0.07 | $0 | |
| 07/13/2021 | Q4 2021 | -$0.61 | -$0.66 | -0.05 | $12.69 M | |
| 03/11/2021 | Q3 2021 | -$0.60 | -$0.56 | 0.04 | $1.20 M | $0 |
| 12/10/2020 | Q2 2021 | -$0.70 | -$0.58 | 0.12 | $625,000 | $0 |
| 09/14/2020 | Q1 2021 | -$0.60 | -$0.61 | -0.01 | $1.50 M | $0 |
| 07/01/2020 | Q4 2020 | -$0.67 | -$0.37 | 0.3 | $3.82 M | |
| 03/10/2020 | Q3 2020 | -$0.56 | -$0.52 | 0.04 | $10.08 M | $1.58 M |
| 12/03/2019 | Q2 2020 | -$0.54 | -$0.33 | 0.21 | $3.27 M | $3.92 M |
KalVista Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is KalVista Pharmaceuticals, Inc.'s earnings date?
KalVista Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 4th, 2024 based off last year's report dates.
-
Did KalVista Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, KalVista Pharmaceuticals, Inc. (:KALV) reported $-0.87 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.95 by $0.08.
-
How can I listen to KalVista Pharmaceuticals, Inc.'s earnings conference call?
The conference call for KalVista Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read KalVista Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for KalVista Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does KalVista Pharmaceuticals, Inc. generate each year?
KalVista Pharmaceuticals, Inc. (:KALV) has a recorded net income of $0. KalVista Pharmaceuticals, Inc. has generated $-3.44 earnings per share over the last four quarters.
-
What is KalVista Pharmaceuticals, Inc.'s price-to-earnings ratio?
KalVista Pharmaceuticals, Inc. (:KALV) has a price-to-earnings ratio of -3.67 and price/earnings-to-growth ratio is 0.96.
